Digital diabetes management company Glooko has announced the appointments of a new CCO and COO.
The first role went to Zach Henderson, formerly of LexisNexis Health Care and Elsevier, he will be in charge of key strategic partners and revenue generation for Glooko.
“As the leader in diabetes data management, Glooko is integrated with more diabetes and health devices than any other platform in the world, creating an opportunity to provide extensive insights,” Henderson said in a statement. “We have a unique opportunity to improve the lives of those with diabetes by leveraging the global Glooko data platform to advance research and the treatment of patients.”
Komathi Stem, meanwhile, has stepped into the second position to lead product development, clinical research and customer support. In addition to founding and heading her health data analytics startup monARC Bionetworks, Stem held leadership roles at Science 37, Genentech, AstraZeneca, Amgen and Eli Lilly.
“Glooko’s mission to empower people with diabetes to use their data to improve care and contribute real-world data to advance research is completely aligned with my passion to transform research and care using the growing body of real-world data,” Stem said in a statement. “I’m pleased to be joining the Glooko team as we continue leading the way in turning integrated diabetes data into actionable insights for people with diabetes and their providers.”
Real-world evidence platform Aetion has added Cathy Polinsky, CTO of online personal styling service Stitch Fix and a veteran of Amazon, Salesforce and others, to its board of directors. The company hopes that Polinsky’s experience will be able to guide its own data-driven decision-making business.
“In my industry, we often talk about the paradox of choice, about how much data is out there and how more data does not necessarily make things easier for people,” she wrote in a blog post. “That’s what I think the [real-world evidence] space is trying to solve, using existing data to attain insights and to advance personalization.”
Healthcare data company Innovaccer has brought athenahealth founder and former CEO Jonathan Bush onto its board of directors. Bush, who now serves as the executive chairman at Firefly Health after being ousted from his old company, will be working with the Innovaccer brass on its cloud integration efforts, among other areas.
"I'm excited to be part of the Innovaccer team," Bush said in a statement. "While I was proud of athenahealth's cloud-based technology, I’m thrilled to now be working with technology and architecture that is brand new. It's amazing the difference two decades make in technology.”
Former FDA Commissioner Dr. Scott Gottlieb’s latest is yet another board position, this time at genome sequencing startup Illumina. Since stepping away from the agency, Gottlieb has taken on roles at Aetion, Tempus Labs and his old stomping grounds, New Enterprise Associates.
“Illumina will benefit from Scott’s expertise in healthcare and public policy as we work to accelerate the adoption and impact of genomics into the standard of care in oncology, reproductive health and other clinical areas,” CEO Francis deSouza said in a statement.